Maravai LifeSciences Holdings, Inc.MRVINASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-22.19M
↓ 115% below average
Average (6y)
$148.72M
Historical baseline
Range
High:$518.89M
Low:$-22.19M
CAGR
+34.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-22.19M | -136.6% |
| 2023 | $60.67M | -88.3% |
| 2022 | $518.89M | +46.7% |
| 2021 | $353.72M | +179.0% |
| 2020 | $126.78M | +1719.7% |
| 2019 | $6.97M | +283.5% |
| 2018 | $-3.80M | - |